Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kazarov

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Genetics|December 1, 1996
Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformationI Garkavtsev, A Kazarov, A Gudkov, et al.
Development (Cambridge, England)|April 4, 1998
A common precursor for hematopoietic and endothelial cellsK Choi, M Kennedy, A Kazarov, et al.
Development (Cambridge, England)|April 6, 2000
Basic fibroblast growth factor positively regulates hematopoietic developmentP Faloon, E Arentson, A Kazarov, et al.
Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.
Doklady. Biochemistry and Biophysics|October 31, 2024
A Study of the Comparability of the Pharmacodynamic, Toxicological, and Pharmacokinetic Properties of the Reference Drug Pulmozyme® and the Biosimilar Drug Tigerase®M S Aksenova, E N Bocharova, S G Abbasova, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Genetics|December 1, 1996
Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformationI Garkavtsev, A Kazarov, A Gudkov, et al.
Development (Cambridge, England)|April 4, 1998
A common precursor for hematopoietic and endothelial cellsK Choi, M Kennedy, A Kazarov, et al.
Development (Cambridge, England)|April 6, 2000
Basic fibroblast growth factor positively regulates hematopoietic developmentP Faloon, E Arentson, A Kazarov, et al.
Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.
Doklady. Biochemistry and Biophysics|October 31, 2024
A Study of the Comparability of the Pharmacodynamic, Toxicological, and Pharmacokinetic Properties of the Reference Drug Pulmozyme® and the Biosimilar Drug Tigerase®M S Aksenova, E N Bocharova, S G Abbasova, et al.
Pageof 1